Under anesthesia, patients are often given muscle-relaxing neuromuscular blockers to make intubations easier and reduce the skeletal muscle tone during surgery. Using a drug to remove the blocking agent after the operation improves patient recovery and reduces the risk of complications. In the journal Angewandte Chemie, a Canadian research team has now reported a novel broad-spectrum antidote. It consists of two “chalices” that are linked together and cover the two ends of the blocker.
Click here for original story, Double calixarenes bind neuromuscular blockers
Source: Phys.org